DKK1 and non-small cell lung carcinoma: Specifically, the mRNA level of DKK1 which has been reported to promote the migration and invasion of NSCLC by inhibiting the phosphorylation of β-catenin19,20 was significantly upregulated in both crizotinib resistant cell lines.